Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Double-Blind Placebo-Controlled Study of Flonase for Ocular Symptoms in Seasonal Allergic Rhinitis
2015-001727-23Phase 3
- Start
- Jun 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in seasonal allergic rhinitis (SAR) comparing Flonase with Placebo (2 arms). Primary endpoint: Mean change from baseline in rTOSS over 14 days.
02
Drugs
fluticasone propionate
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on 2015-001727-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001727-23.